Every coenzyme earns its place in a cell by doing one job well, and NAD+ (nicotinamide adenine dinucleotide) is unusual in that it holds down two. In research settings it behaves first as an electron carrier and second as a signaling substrate, and understanding why those two jobs are chemically distinct is the starting point for reading almost any study that touches this molecule.
Job one: moving electrons
NAD+ exists in two interconvertible states, oxidized (NAD+) and reduced (NADH), and the difference between them is a single hydride ion parked on the nicotinamide ring. Enzymes in glycolysis, the citric acid cycle, and fatty acid oxidation strip electrons from fuel molecules and hand them to NAD+, converting it to NADH. That NADH then delivers its electrons to the mitochondrial electron transport chain, where the energy is ultimately captured as ATP through oxidative phosphorylation. In research models, the NAD+/NADH ratio is often treated as a proxy for a cell's overall redox state and metabolic activity — a lower ratio broadly signals a more reduced, energy-taxed environment.
Job two: a consumable signaling substrate
The second role is chemically unrelated to electron transport. Two enzyme families — sirtuins and poly(ADP-ribose) polymerases (PARPs) — use NAD+ not as a reversible cofactor but as a substrate they break apart entirely. Sirtuins cleave NAD+ to remove acetyl groups from target proteins, a reaction studied in chromatin-regulation and metabolic-signaling research. PARPs consume NAD+ to build poly(ADP-ribose) chains at sites of DNA damage, a step examined in DNA-repair and genome-stability research. Because both enzyme families draw from the same finite intracellular NAD+ pool, researchers studying one pathway often need to account for competing demand from the other.
Why the dual role matters for study design
This split identity is a large part of why NAD+ shows up across such disparate research areas — bioenergetics on one side, aging- and genome-stability biology on the other — and why in-vitro models sometimes measure both compartments (NADH-linked respiration and sirtuin/PARP activity) to build a fuller picture. It's also why NAD+ availability itself, not just its redox cycling, is treated as a variable of interest in cell-based assays. For the metabolic side of this picture, see NAD+ in cellular and metabolic research; for the range of downstream applications this dual mechanism supports, see NAD+ research applications.
Research-grade NAD+ used in these models is sourced as a defined, purified compound rather than a peptide chain; see NAD+ research vials for the material specification.
Research Use Only. Supplied strictly for laboratory research and development — not for human or veterinary use, consumption, or any therapeutic or diagnostic purpose. This article is research education, not usage guidance.